Given the absence of obesity in this double-hit GDM model, the results clearly indicate that impaired insulin secretion driven pregnancy hyperglycaemia has a distinct contribution to the development of postpartum MASLD. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.